Business Insights
  • Home
  • Crypto
  • Finance Expert
  • Business
  • Invest News
  • Investing
  • Trading
  • Forex
  • Videos
  • Economy
  • Tech
  • Contact

Archives

  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • August 2023
  • January 2023
  • December 2021
  • July 2021
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019

Categories

  • Business
  • Crypto
  • Economy
  • Finance Expert
  • Forex
  • Invest News
  • Investing
  • Tech
  • Trading
  • Uncategorized
  • Videos
Apply Loan
Money Visa
Advertise Us
Money Visa
  • Home
  • Crypto
  • Finance Expert
  • Business
  • Invest News
  • Investing
  • Trading
  • Forex
  • Videos
  • Economy
  • Tech
  • Contact
2 Monster Growth Stocks to Buy and Hold for 10 Years
  • Finance Expert

2 Monster Growth Stocks to Buy and Hold for 10 Years

  • May 24, 2025
  • Roubens Andy King
Total
0
Shares
0
0
0
Total
0
Shares
Share 0
Tweet 0
Pin it 0
  • Shopify should benefit from the switch to e-commerce thanks to its strong position and competitive edge.

  • Vertex Pharmaceuticals' expanding lineup and deep pipeline can help it overcome recent headwinds.

  • 10 stocks we like better than Shopify ›

The market's recent correction looks like a massive drop on a year-to-date chart. However, it will look far less daunting in a decade; that's what happens over the long run. Bull markets last longer than downturns. This leads to relatively smooth (though not flawless) northbound trajectories and strong returns for most stocks over a decade or more.

Despite recent market volatility, buying shares of top companies that can at least match average returns through 2035 — or do much better — is still worth it. Here are two excellent candidates: Shopify (NASDAQ: SHOP) and Vertex Pharmaceuticals (NASDAQ: VRTX).

Image source: Getty Images.

The world is constantly changing and evolving. Many businesses don't last long because they fail to change with it. Take the continued rise of e-commerce: Well-established brick-and-mortar stores have been driven to the brink of bankruptcy (or beyond) as retail transactions increasingly switch to online channels. Shopify is one of the companies helping drive this shift, as it allows merchants to create online storefronts, practically a necessity for success in our modern digital world.

E-commerce should continue growing over the next decade. In the U.S., it accounted for just 16.2% of retail transactions in the first quarter. That number will increase, and Shopify should benefit significantly.

For one thing, the company has been an innovator in its niche of the e-commerce market. It's now a one-stop shop for everything businesses need to start online stores. Shopify provides a slew of services, including marketing, payment processing, inventory management, and much more, so business owners can focus on other things. And it consistently generates solid and rapidly growing revenue.

For another, Shopify has a strong competitive advantage based on switching costs. Having a moat is necessary to perform well over the long run, and Shopify doesn't fall short on this front.

However, it still isn't consistently profitable, and there's stiff competition in the e-commerce market. Meanwhile, an economic downturn could affect transaction volume on its platform and, by extension, its revenue.

Yet Shopify should still perform well in the next decade as it makes headway in the large e-commerce market. Changes it implemented a few years ago — notably, selling its logistics unit — have allowed it to get much closer to profitability. And despite the competition, Shopify has grabbed more than a 12% share (by gross merchandise volume) of the U.S. e-commerce industry.

The stock might slow down in the face of economic issues, but those don't last forever. In the long run, Shopify should deliver superior returns.

Vertex Pharmaceuticals, a leading biotech company, has encountered some headwinds lately. In December, it failed to impress the market with phase 2 results for suzetrigine in treating painful lumbosacral radiculopathy (low back and leg pain caused by inflammation of nerves in the spine). More recently, Vertex's shares fell off a cliff after disappointing first-quarter results.

Even with those recent headwinds, the company's outlook for the next decade seems attractive. The biotech's portfolio of products remains the proverbial “only game in town” for patients with the rare lung disease cystic fibrosis (CF). Vertex is the only company that makes medicines that address the underlying causes of CF. That's still helping drive strong top-line growth.

The biotech missed expectations in the first quarter for two reasons that won't haunt it every period. It dealt with illegal knockoffs of its medicines in Russia — a problem isolated to that country. And it incurred a noncash impairment charge related to an investigational drug for type 1 diabetes (T1D), VX-264, which it recently discontinued.

Meanwhile, Vertex Pharmaceuticals' already strong CF franchise recently improved with the approval of Alyftrek, a next-gen medicine. The company can still make significant strides in this market.

And Vertex is expanding its lineup beyond its core area. Recent approvals like that for Casgevy, a gene-editing medicine for two rare blood diseases, and Journavx, for acute pain, will help drive top-line growth. Even in T1D, Vertex's other program, VX-880, could hit regulators' desks seeking approval by next year. The company has several other medicines in development, some in phase 3 studies.

Vertex Pharmaceuticals may not have performed well recently, but at current levels, it's a great idea to buy the stock. Those who do so today should see strong returns through 2035.

Before you buy stock in Shopify, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Shopify wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004… if you invested $1,000 at the time of our recommendation, you’d have $639,271!* Or when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $804,688!*

Now, it’s worth noting Stock Advisor’s total average return is 957% — a market-crushing outperformance compared to 167% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of May 19, 2025

Prosper Junior Bakiny has positions in Shopify and Vertex Pharmaceuticals. The Motley Fool has positions in and recommends Shopify and Vertex Pharmaceuticals. The Motley Fool has a disclosure policy.

2 Monster Growth Stocks to Buy and Hold for 10 Years was originally published by The Motley Fool

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Roubens Andy King

Previous Article
McDonald's menu adds breakfast twist on Snack Wraps
  • Trading

McDonald's menu adds breakfast twist on Snack Wraps

  • May 24, 2025
  • Roubens Andy King
Read More
Next Article
  • Invest News

Rethinking the Institutional Mandate: A Compilation from Enterprising Investor

  • May 24, 2025
  • Roubens Andy King
Read More
You May Also Like
CoreWeave’s stock slides as insider selling sparks investor concerns
Read More
  • Finance Expert

CoreWeave’s stock slides as insider selling sparks investor concerns

  • Roubens Andy King
  • September 2, 2025
Is CAT Outperforming the Industrial Sector?
Read More
  • Finance Expert

Is CAT Outperforming the Industrial Sector?

  • Roubens Andy King
  • September 2, 2025
Crude oil climbs on Russian supply risks; Russia and China agree on huge new gas pipeline
Read More
  • Finance Expert

Crude oil climbs on Russian supply risks; Russia and China agree on huge new gas pipeline

  • Roubens Andy King
  • September 2, 2025
Nestlé fired its scandal-clad CEO without a payout—a ‘really unusual’ move, expert says
Read More
  • Finance Expert

Nestlé fired its scandal-clad CEO without a payout—a ‘really unusual’ move, expert says

  • Roubens Andy King
  • September 2, 2025
‘Her kids will have no inheritance’: Will my friend lose her house to Medicaid if she goes into a nursing home?
Read More
  • Finance Expert

‘Her kids will have no inheritance’: Will my friend lose her house to Medicaid if she goes into a nursing home?

  • Roubens Andy King
  • September 2, 2025
Analyst Report: Caterpillar Inc.
Read More
  • Finance Expert

Analyst Report: Caterpillar Inc.

  • Roubens Andy King
  • September 2, 2025
AbbVie’s Elahere gains approval in Canada for ovarian cancer
Read More
  • Finance Expert

AbbVie’s Elahere gains approval in Canada for ovarian cancer

  • Roubens Andy King
  • September 2, 2025
Microsoft CEO Satya Nadella reveals 5 AI prompts that can ‘supercharge your everyday workflow’
Read More
  • Finance Expert

Microsoft CEO Satya Nadella reveals 5 AI prompts that can ‘supercharge your everyday workflow’

  • Roubens Andy King
  • September 2, 2025

Recent Posts

  • AI Adoption Set to Reshape Healthcare, Finance, Logistics | World Business Watch | WION
  • Master Investing with This Game-Changing Strategy! #shorts #finance
  • Federal Reserve Board – Federal Reserve Board issues enforcement actions with former employee of Ally Bank and former employee of Regions Bank
  • Between Truth and Turmoil: Dakota Mortensen Reacts to Taylor Frankie Paul’s Abuse Allegations
  • Mohnish Pabrai: FASTEST Way To Financial Freedom! Proven Playbook For Quitting Your 9-5 In 9 Months!
Featured Posts
  • AI Adoption Set to Reshape Healthcare, Finance, Logistics | World Business Watch | WION 1
    AI Adoption Set to Reshape Healthcare, Finance, Logistics | World Business Watch | WION
    • March 21, 2026
  • Master Investing with This Game-Changing Strategy! #shorts #finance 2
    Master Investing with This Game-Changing Strategy! #shorts #finance
    • March 20, 2026
  • Federal Reserve Board – Federal Reserve Board issues enforcement actions with former employee of Ally Bank and former employee of Regions Bank 3
    Federal Reserve Board – Federal Reserve Board issues enforcement actions with former employee of Ally Bank and former employee of Regions Bank
    • March 20, 2026
  • Between Truth and Turmoil: Dakota Mortensen Reacts to Taylor Frankie Paul’s Abuse Allegations 4
    Between Truth and Turmoil: Dakota Mortensen Reacts to Taylor Frankie Paul’s Abuse Allegations
    • March 20, 2026
  • Mohnish Pabrai: FASTEST Way To Financial Freedom! Proven Playbook For Quitting Your 9-5 In 9 Months! 5
    Mohnish Pabrai: FASTEST Way To Financial Freedom! Proven Playbook For Quitting Your 9-5 In 9 Months!
    • March 19, 2026
Recent Posts
  • Federal Reserve Board – Agencies request comment on proposals to modernize the regulatory capital framework and maintain the strength of the banking system
    Federal Reserve Board – Agencies request comment on proposals to modernize the regulatory capital framework and maintain the strength of the banking system
    • March 19, 2026
  • China Import Made Easy | Start Business with Sea Cargo 100 PKR per Kg
    China Import Made Easy | Start Business with Sea Cargo 100 PKR per Kg
    • March 18, 2026
  • Federal Reserve Board – Federal Reserve issues FOMC statement
    Federal Reserve Board – Federal Reserve issues FOMC statement
    • March 18, 2026
Categories
  • Business (2,057)
  • Crypto (2,023)
  • Economy (235)
  • Finance Expert (1,687)
  • Forex (2,016)
  • Invest News (2,449)
  • Investing (2,040)
  • Tech (2,056)
  • Trading (2,024)
  • Uncategorized (2)
  • Videos (1,007)

Subscribe

Subscribe now to our newsletter

Money Visa
  • Privacy Policy
  • DMCA
  • Terms of Use
Money & Invest Advices

Input your search keywords and press Enter.